• Abbott Buys Facet Biotech for $722 Million
  From Facet Biotech
  Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline. ... (Read more)
• Scientists Shed New Light On How Retina's Hardware Is U...
  From Medical News Today
  Biologists at New York University and the University of Würzburg have identified, in greater detail, how the retina's cellular hardware is used in color preference. The ... (Read more)
• ISTA says FDA to review eye drug by Oct. 16
  From Associated Press
  ISTA Pharmaceuticals Inc. said Monday the Food and Drug Administration will make a regulatory decision on the once-daily eye inflammation treatment XiDay by Oct. 16. The ... (Read more)
• Cataract risk increases with anti-depressants
  From The Times of India
  Researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University have found that some anti-depressant drugs are associ... (Read more)
• High eye pressure: monitor or treat?
  From Washington University in St. Louis
  Most people at risk for developing glaucoma due to high eye pressure do not need treatment, according to a large, multi-center study. The Ocular Hypertension Treatment St... (Read more)

Subscribe to EyewireToday.com